Marken Launches Solo For Management of Clinical Trials Distribution

Article

Company News Release

Marken announced the launch of Solo™, their proprietary web based system used to manage the regulatory, inventory, and operational supply chain complexities of clinical trials. The system, which has been developed exclusively for Marken, is designed to manage all aspects of Marken’s global depot network including: receipt of clinical supplies and kits, dispatches, returns, warehouse movements, and QA releases. Solo™ is a secure, validated*, web-based system which is fully accessible to Marken’s clients on a 24/7 basis from any location in the world. Additionally, Marken has designed Solo™ to integrate with multiple client-directed IXR (Interactive Reporting) systems.

“We are pleased to offer this new system to our growing number of pharmaceutical clients”, said Frank Wright, Interim President, Clinical Trials Distribution at Marken.

“Solo is fit for purpose application which incorporates all of our client’s requirements for remote storage and distribution of their clinical trial supplies. We are also excited to be launching Solo as we manage an increasing number of depots around the world”. Solo™ is purpose-built to allow a high degree of customization supporting the dynamic needs of Marken’s pharmaceutical client base. The system is being launched just as Marken is opening its third fully owned and staffed depot facility in Buenos Aires, Argentina.

*validated in accordance with 21 CFR part 11

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.